ECG T Wave

Overview

4.6 out of 5 (22 Reviews)

Credits

1.00

Post-Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

7 Nov 2025

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6279 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7487.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

T-wave abnormalities on electrocardiography represent a broad spectrum of conditions ranging from benign physiologic variants to life-threatening pathologies. Normal repolarization of the ventricles typically produces upright T waves in most leads; however, alterations in ion channel function, myocardial structure, or systemic physiology can modify the morphology of T waves. Variations include inversion, peaking, flattening, or biphasic forms, each of which may indicate a different underlying disorder. Myocardial ischemia, pulmonary embolism, electrolyte disturbances, myocarditis, and structural cardiomyopathies are among the most clinically significant etiologies. Conversely, normal variants can mimic severe disease yet require no intervention. Accurate recognition of these abnormalities is essential for guiding diagnostic testing, initiating targeted therapies, and preventing unnecessary procedures that may lead to iatrogenic harm. Prognosis is highly dependent on timely diagnosis and management of the underlying condition, underscoring the importance of clinician expertise in interpreting T-wave findings.

After participating in this course, learners gain competence in identifying, interpreting, and responding to abnormal T-wave morphology. The clinician develops the ability to differentiate between benign variants and pathologic changes, integrating electrocardiographic findings with history, physical examination, and laboratory data. Enhanced knowledge of the conditions associated with T-wave abnormalities supports appropriate referral, consultation, and management. Collaboration with the interprofessional healthcare team, including nurses, telemetry technicians, emergency clinicians, cardiologists, nephrologists, and critical care specialists, enhances the recognition and communication of time-sensitive abnormalities, such as myocardial ischemia, pulmonary embolism, and hyperkalemia. Coordinated care ensures prompt treatment, reduces diagnostic delays, and optimizes patient outcomes. By fostering shared expertise across disciplines, the activity equips clinicians to provide safer and more effective patient-centered care.


UAN: JA4008338-0000-23-1554-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify abnormal T-wave morphologies on electrocardiography and distinguish them from normal variants.

  • Interpret T-wave abnormalities in the context of patient history, examination findings, and laboratory data to determine underlying pathology.

  • Differentiate benign T-wave changes from those associated with life-threatening conditions such as myocardial ischemia, pulmonary embolism, and hyperkalemia.

  • Collaborate effectively with the interprofessional healthcare team, including nurses, technicians, cardiologists, nephrologists, and critical care specialists, to optimize patient outcomes.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-1554-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Darcey A. on 3/15/2021

Matthew W. on 12/13/2021

Scott S. on 3/3/2022

Milda P. on 6/4/2022

Matthew K. on 8/3/2022

jiho y. on 10/18/2022

Maylin G. on 11/15/2022

Karl S. on 2/16/2023

Brian B. on 4/4/2023

dana c. on 4/23/2023

Nathaniel S. on 5/30/2023

PEGGY J. on 4/28/2024

Richard B. on 6/2/2024

Melissa H. on 11/6/2024

Christine G. on 12/13/2024

Crystal B. on 1/31/2025

Kristine S. on 3/3/2025

Marilyn M. on 10/10/2025

C J. on 10/23/2025

Jim P. on 1/12/2026

Malene W. on 2/23/2026

Joyce B. on 5/30/2026

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6279 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7487.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$139 per 1 year per user